BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16600085)

  • 1. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
    Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China.
    Chen L; Jin T; Huang B; Chang X; Lei L; Nordberg GF; Nordberg M
    Toxicol Sci; 2006 May; 91(1):104-12. PubMed ID: 16322080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
    Chen L; Jin T; Huang B; Nordberg G; Nordberg M
    Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method].
    Hong F; Jin TY; Zhang AH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):374-8. PubMed ID: 15569507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of metallothionein gene isoforms expression as biomarkers in cadmium exposure].
    Chang XL; Jin TY; Chen L; Lei LJ; Zhou YF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):12-5. PubMed ID: 16600086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
    Chang X; Jin T; Chen L; Nordberg M; Lei L
    Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal dysfunction in workers exposed to arsenic and cadmium].
    Hong F; Jin TY; Lu GD; Yin ZY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec; 21(6):432-6. PubMed ID: 14761355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of Benchmark dose (BMD) in estimating biological exposure limit (BEL)].
    Shao B; Jin TY; Qian HL; Wu XW; Kong QH; Ye TT
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):20-2. PubMed ID: 16600088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters.
    Lei LJ; Chen L; Jin TY; Nordberg M; Chang XL
    Toxicol Sci; 2007 May; 97(1):189-95. PubMed ID: 17303580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of cadmium and arsenic interactions.
    Nordberg GF; Jin T; Hong F; Zhang A; Buchet JP; Bernard A
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):191-7. PubMed ID: 15967208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population.
    Chen L; Lei L; Jin T; Nordberg M; Nordberg GF
    Diabetes Care; 2006 Dec; 29(12):2682-7. PubMed ID: 17130205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium.
    Lu J; Jin T; Nordberg G; Nordberg M
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):150-6. PubMed ID: 15967203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].
    Rutowski J; Moszczyński P
    Przegl Lek; 2006; 63 Suppl 7():65-73. PubMed ID: 17784548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
    Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
    Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships.
    Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmark dose approach for renal dysfunction in workers exposed to lead.
    Lin T; Tai-Yi J
    Environ Toxicol; 2007 Jun; 22(3):229-33. PubMed ID: 17497640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead].
    Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R
    Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of benchmark dose for bone damage and renal dysfunction in a Chinese male population occupationally exposed to lead.
    Sun Y; Sun D; Zhou Z; Zhu G; Lei L; Zhang H; Chang X; Jin T
    Ann Occup Hyg; 2008 Aug; 52(6):527-33. PubMed ID: 18567606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein gene expression in peripheral lymphocytes from cadmium-exposed workers.
    Lu J; Jin T; Nordberg G; Nordberg M
    Cell Stress Chaperones; 2001 Apr; 6(2):97-104. PubMed ID: 11599580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China.
    Nordberg GF
    Toxicol Lett; 2010 Jan; 192(1):45-9. PubMed ID: 19540908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.